Abstract:Objective: Adoptive immunotherapy with gamma delta T cells may be a promising cancer treatment because of its specificity. Zoledronate can be used in gamma delta T cell expansion protocol in vitro. However, more effective amplification strategies should be explored. This study aims to investigate the effect of gamma delta T cell proliferation following co-culturing peripheral blood mononuclear cells (PBMCs) with autologous dendritic cells (DCs) pretreated with zoledronate. Method: Peripheral blood derived DCs and co-culturing PBMCs were treated with 1 mu mol/L zoledronate for 48 h at the fifth day of incubation at 37 degrees C with 5% CO2. Cell flow cytometry was performed for checking the cells ratio and content. Modulation by zoledronate of DC surface marker expression and changes in gamma delta T cell proportions were measured by ELISA and Q-PCR. Total RNA was extracted by TRIZOL method. The isopentenylpyrophosphate (IPP) content in the supernatant of the specimen under different stimulating conditions was analyzed by high performance liquid chromatographytandem mass spectrometry (LC-MS/ MS). Results: Approximately 1 mu mol/L zoledronate did not induce maturation of immature DCs, as manifested by the reduced expressions of HLA-DR, CD80 and CD86, whereas specific marker CD11c remained unchanged. Following treatment of DCs and co-culturing PBMCs with zoledronate, the number of gamma delta T cells significantly increased (from 4.99% to 65.7%, n = 3, P < 0.05). In comparison, gamma delta T cells increased from 4.96% to 34.1% (n = 3, P < 0.05) with the treatment of PBMCs with zoledronate. Cytoplasmic granule-associated proteins perforin, granzyme B, and CD107a were enhanced correspondingly. Hence, increasing zoledronate concentration caused the increase of IPP, and the stimulating ability was abrogated by mevastatin. Conclusion: Following treatment of DCs and co-culturing PBMCs with zoledronate, gamma delta T cell proliferation can be significantly induced. This method of generating gamma delta T cells is eligible for gamma delta T cell adoptive immunotherapy for lung cancer.

TypeI IFN-mediated Enhancement of Anti-Osteosarcoma Cytotoxicity of Human Gammadelta T Cells

[Effect of Zoledronate on the Cytotoxicity of Γδ T Cells from PBMCs of Osteosarcoma Patients Against Osteosarcoma].

[Amplification of Γδ T Cells in PBMCs of Healthy Donors and Osteosarcoma Patients Stimulated by Zoledronate].

IFN-γ Enhances HOS and U2OS Cell Lines Susceptibility to Γδ T Cell-Mediated Killing Through the Fas/Fas Ligand Pathway

Allogenic Γδ T Cell and Tumor Cell Fused Vaccine for Enhanced Immunotherapeutic Efficacy of Osteosarcoma

Experimental Study on Apoptosis of Osteosarcoma Cell Induced by TRAIL Combined with IFN-γ

Decitabine Enhances Vγ9Vδ2 T Cell-Mediated Cytotoxic Effects on Osteosarcoma Cells Via the NKG2DL–NKG2D Axis

Trastuzumab Enhanced the Cytotoxicity of Vγ9Vδ2 T Cells Against Zoledronate-Sensitized Osteosarcoma Cells

Valproic Acid Combined with Zoledronate Enhance Γδ T Cell-Mediated Cytotoxicity Against Osteosarcoma Cells Via the Accumulation of Mevalonate Pathway Intermediates.

Sensitization of Human Osteosarcoma Cells to Vγ9Vδ2 T‐cell‐mediated Cytotoxicity by Zoledronate

Zoledronate Increases Gamma Delta T Cell Proliferation Through Co-Culturing Peripheral Blood Mononuclear Cells With Autologous Dendritic Cells

IFN-γ Promotes Graft-Versus-leukemia Effects Without Directly Interacting with Leukemia Cells in Mice after Allogeneic Hematopoietic Cell Transplantation.

Study on the effect of γδ T cells expanded in vitro to kill hepatocellular carcinoma cells

Type I Interferon Suppresses Tumor Growth Through Activating the STAT3-granzyme B Pathway in Tumor-Infiltrating Cytotoxic T Lymphocytes

Type I Interferons Exert Anti-Tumor Effect Via Reversing Immunosuppression Mediated by Mesenchymal Stromal Cells.

Inhibition Effects of IFN-γ on TNF-α Enhanced Proliferation of OSF-Derived Fibroblasts

Efficacy of Ifosfamide Combined with Liposome Doxorubicin on Osteosarcoma and Its Effects on Serum IL-10, TNF-α, and IFN-γ in Patients with Osteosarcoma.

Killing activity in vitro of γδT cells against human hematologic neoplasms cells

Cytotoxicity of Human Hepatic Intrasinusoidal Gamma/Delta T Cells Depends on Phospho-antigen and NK Receptor Signaling

IFNγ Production by Functionally Reprogrammed Tregs Promotes Antitumor Efficacy of OX40/CD137 Bispecific Agonist Therapy

An Essential Role for IFN-gamma in Regulation of Alloreactive CD8 T Cells Following Allogeneic Hematopoietic Cell Transplantation.